Accordingly, p130Cas is overexpressed in human triple-negative breast cancer (Tornillo et al., 2013; Table 1), implying that the increased expression of p130Cas may be a priming event for the onset of basal-like breast cancer. The gene discussed is BCAR1; the disease is breast carcinoma.